Corticorelin ovine triflutate

Synthetic ACTH (1 24) AnalogRx: PrescriptionCompound: Approved

Also known as: ACTH (1-24), Acthrel, corticorelin, Cortrosyn, Cosyntropin, CRF (ovine), oCRH, ovine CRH, Tetracosactide

Educational Only — Not medical advice. Consult a qualified clinician before using any peptide.

Source Corticorelin ovine triflutate at Peptiology

Save 10% with code PEPTI-BOSSRABBIT-10

Shop Now & Save 10% →

Affiliate link: we earn a commission on purchases made through this link, at no extra cost to you.

Tapping Shop Now & Save 10% copies your 10% off code PEPTI-BOSSRABBIT-10 to your clipboard. Paste it at the Peptiology checkout to claim the discount.

Summary

Corticorelin ovine triflutate (Acthrel) is a synthetic form of ovine corticotropin-releasing hormone used as a diagnostic agent to distinguish pituitary-dependent Cushing's disease from ectopic ACTH syndrome and adrenal tumors. It stimulates pituitary ACTH secretion and is administered as an intravenous injection for the differential diagnosis of ACTH-dependent hypercortisolism.

Mechanism of Action

Synthetic ovine corticotropin-releasing hormone (oCRH) that binds to CRH receptors on pituitary corticotroph cells, stimulating the synthesis and release of adrenocorticotropic hormone (ACTH) and beta-endorphin. Used diagnostically to differentiate the source of excess ACTH production.

Routes of Administration

IntramuscularIntravenousSubcutaneous

Goals & Uses

  • ACTH stimulation testDiagnosticHigh
  • Assessment of adrenal insufficiencyDiagnosticHigh
  • Differential diagnosis of Cushing's syndromeDiagnosticHigh
  • Inferior petrosal sinus sampling (IPSS) adjunctDiagnosticHigh
  • Evaluation of hypothalamic-pituitary-adrenal (HPA) axis functionDiagnosticModerate

Contraindications

  • Concurrent heparin administrationDrug InteractionModerate
  • Hypersensitivity to cosyntropin or any component of the formulationAllergyHigh
  • Hypersensitivity to corticorelin or ovine proteinsAllergy/ImmunologyHigh

Adverse Effects

  • AnaphylaxisImmunologicRareSevere life-threatening allergic reaction
  • Facial flushingCardiovascular/DermatologicCommon
  • Injection site reactionsLocalUncommon
  • HeadacheNeurologicCommonPain in the head or upper neck
  • HypotensionCardiovascularUncommonLow blood pressure
  • FlushingVascularCommonWarmth and redness of the skin
  • TachycardiaCardiovascularUncommonAbnormally fast heart rate
  • NauseaGastrointestinalCommonFeeling of sickness or urge to vomit
  • DyspneaRespiratoryRareShortness of breath

Drug Interactions

  • HeparinModerate
  • KetoconazoleModerate
  • Exogenous glucocorticoidsModerate
  • Glucocorticoids (exogenous)Moderate
  • MetyraponeLow

Population Constraints

  • PregnancyReproductive SafetyRelative
  • Pediatric patientsAgeRelative
  • ElderlyAgeRelative
  • Patients with known allergy to ovine proteinsAllergyAbsolute

Regulatory Status

  • European UnionApprovedApproved: ACTH stimulation testEMA‑approved under similar indications.
  • United StatesApprovedApproved: ACTH stimulation testFDA‑approved as Cosyntropin for diagnostic use.
  • United KingdomApprovedApproved: ACTH stimulation testMHRA‑approved.

Approved for diagnostic evaluation of adrenal insufficiency and for assessment of cortisol reserve.

Evidence & Sources

Frequently Asked Questions

What is Corticorelin ovine triflutate?

Corticorelin ovine triflutate (Acthrel) is a synthetic form of ovine corticotropin-releasing hormone used as a diagnostic agent to distinguish pituitary-dependent Cushing's disease from ectopic ACTH syndrome and adrenal tumors. It stimulates pituitary ACTH secretion and is administered as an intravenous injection for the differential diagnosis of ACTH-dependent hypercortisolism.

What is Corticorelin ovine triflutate used for?

Corticorelin ovine triflutate is educationally associated with: ACTH stimulation test, Assessment of adrenal insufficiency, Differential diagnosis of Cushing's syndrome, Inferior petrosal sinus sampling (IPSS) adjunct, Evaluation of hypothalamic-pituitary-adrenal (HPA) axis function. Educational only — not medical advice.

How is Corticorelin ovine triflutate administered?

Recorded routes of administration: Intramuscular, Intravenous, Subcutaneous.

What are the potential side effects of Corticorelin ovine triflutate?

Reported adverse effects include: Anaphylaxis, Facial flushing, Injection site reactions, Headache, Hypotension, Flushing, Tachycardia, Nausea, Dyspnea. This list is not exhaustive — consult a qualified clinician.

Who should avoid Corticorelin ovine triflutate?

Recorded contraindications: Concurrent heparin administration, Hypersensitivity to cosyntropin or any component of the formulation, Hypersensitivity to corticorelin or ovine proteins. Consult a qualified clinician before use.

More Melanocortin and ACTH Analogues

See all Melanocortin and ACTH Analogues →